Another drug with a high possibility of causing depression is infliximab, the first tumor necrosis factor α (TNF-α) antagonist used to treat chronic inflammatory diseases, and characterized by rapid therapeutic effect and high bioavailability. This evidence concerns the gene TNF and depressive symptom measurement.